LifeScience Clinical & Diagnostic

RemeGen and Innovent Collaborate on Clinical Trials for Advanced Solid Tumors

RemeGen Co., Ltd. ("RemeGen" or "the Company") (HKG: 9995, SHA: 688331), a fully-integrated commercial-stage biotechnology company, announce...

 July 10, 2023 | News

Sirnaomics Forms Strategic Partnership with EDIRNA Inc. in RNA-Editing Therapeutics

EDIRNA is a start-up biotech company focusing on RNA-Editing therapeutics and taking advantage of the Group's proprietary technology platforms for novel RN...

 July 06, 2023 | News

TiumBio and Hansoh Pharma Secure NMPA Approval for 'HS-10518/TU2670' Clinical Trial in China

TiumBio will complete the last patient dosing in a Phase 2a clinical trial of TU2670 in endometriosis in Europe by the end of the year TiumBio C...

 July 06, 2023 | News

Gilead Sciences and IAS Honor Global Healthcare Providers for Stigma-Free HIV Services

The 2023 Me and My Healthcare Provider (MMHCP) campaign, supported by Gilead for the second year running, honours frontline workers providing exemplary inc...

 July 05, 2023 | News

Zymedi Collaborates with National Heart, Lung, and Blood Institute to Develop ZMA001 mAb for PAH Treatment

  The CRADA between Zymedi and the NHLBI will enable the organizations to collaborate together to advance the development of ZMA001. Zymedi will work...

 July 03, 2023 | News

Promising Clinical Trial Data for Migraine Treatment: CER-0001, a Ketogenic Investigational Agent

A poster showcasing data from the RELIEF study of CER-0001 (tricaprilin), being investigated for the preventive treatment of migraine, was presented at t...

 July 03, 2023 | News

Thermo Fisher Scientific Introduces Tumor Culture Medium for Faster Cancer Treatment Development

Thermo Fisher Scientific, a global leading company in science services, today announced the launch of the Gibco™ OncoPro™ tumor media kit. *, t...

 June 29, 2023 | News

Lo.Li. Pharma Sets New World Record in PCOS and Infertility Awareness Campaign with International Partners

The record-breaking event aimed to raise awareness about non-pharmacological options for managing polycystic ovary syndrome (PCOS) and infertility. The ini...

 June 29, 2023 | News

Verona Pharma Partners with Nuance Pharma, Submits Ensifentrine NDA to US FDA for COPD Maintenance Treatment

Ensifentrine is a selective dual inhibitor of the enzymes phosphodiesterase 3 and 4 combining bronchodilator and non-steroidal anti-inflammatory activities...

 June 29, 2023 | News

Lymphoma Therapy Approved for Australian Patients with Diffuse Large B-cell Lymphoma

MINJUVI® (tafasitamab) provisionally approved by Therapeutic Goods Administration[1] Recent five-year follow-up data from Phase 2 L-MIND investig...

 June 28, 2023 | News

INOVIQ's SubB2M/CA15-3 Breast Cancer Test Shows Excellent Clinical Data

INOVIQ's SubB2M/CA15-3 breast cancer test detects all-stages of breast cancer with excellent accuracy (87%), sensitivity (81%) and specificity (93%) The...

 June 28, 2023 | News

CStone Receives China NMPA Approval for GAVRETO® in First-Line Treatment of RET Fusion-Positive Lung Cancer.

  The approval for the first-line treatment of RET fusion-positive non-small cell lung cancer marks the third indication of GAVRETO in Mainland Chi...

 June 27, 2023 | News

Prenetics and Prof. Dennis Lo Launch US$200m Joint Venture "Insighta" for Multi-Cancer Early Detection

- Insighta is a 50/50 Joint Venture by Prenetics and Professor Dennis Lo. - Insighta is powered by technology developed by the Centre for Novostics w...

 June 26, 2023 | News

Cognigenics' Intranasal CRISPR Delivery Overcomes Blood-Brain Barrier; Promising Therapeutic Breakthrough

Cognigenics CEO John L. Mee announces breakthrough results from an animal study published today in PNAS Nexus. The findings point to the pot...

 June 23, 2023 | Analysis


News

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close